Nucleic Acid Testing Market

1. Executive Summary

2. Introduction
     2.1. Study Objectives
     2.2. Market Definition
          2.2.1. Market Covered
          2.2.2. Geographical Coverage
          2.2.3. Study Years & Currency
     2.3. Market Stakeholders
     2.4. Key Questions this Study will Answer
     2.5. GMI Research’s Approach & Methodology

3. Global Nucleic Acid Testing Market - Overview
     3.1. Introduction
     3.2. Market Segmentation
     3.3. Value Chain Analysis
     3.4. Drivers
     3.5. Restraints
     3.6. Trends

4. Global Nucleic Acid Testing Market Revenue Forecast till 2025

5. Global Nucleic Acid Testing Market by Product Type Revenue Forecast till 2025
     5.1. Nucleic Acid test Kits
          5.1.1. Transcription-mediated amplification (TMA)
          5.1.2. Polymerase chain reaction (PCR)
          5.1.3. Ligase chain reaction (LCR)
          5.1.4. Whole genome sequencing
     5.2. Consumables

6. Global Nucleic Acid Testing Market by Indication Revenue Forecast till 2025
     6.1. Infectious diseases
     6.2. Cancer
     6.3. Forensic Testing
     6.4. Others

7. Global Nucleic Acid Testing Market by End User Revenue Forecast till 2025
     7.1. Hospitals
     7.2. Pathology laboratories
     7.3. Research Institutes
     7.4. Clinics

8. Global Nucleic Acid Testing Market by Geography Revenue Forecast till 2025

     8.1. North America Nucleic Acid Testing Market Revenue Forecast till 2025
          8.1.1. North America Nucleic Acid Testing Market by Product Type (Option 1: 25% customization)
                    8.1.1.1. Nucleic Acid test Kits
                           8.1.1.1.1. Transcription-mediated amplification (TMA)
                           8.1.1.1.2. Polymerase chain reaction (PCR)
                           8.1.1.1.3. Ligase chain reaction (LCR)
                           8.1.1.1.4. Whole genome sequencing
                    8.1.1.2. Consumables

          8.1.2. North America Nucleic Acid Testing Market by Indication
                    8.1.2.1. Infectious diseases
                    8.1.2.2. Cancer
                    8.1.2.3. Forensic Testing
                    8.1.2.4. Others

          8.1.3. North America Nucleic Acid Testing Market by End User
                    8.1.3.1. Hospitals
                    8.1.3.2. Pathology laboratories
                    8.1.3.3. Research Institutes
                    8.1.3.4. Clinics

     8.2. Europe Nucleic Acid Testing Market Revenue Forecast till 2025
          8.2.1. Europe Nucleic Acid Testing Market by Product Type (Option 2: 25% customization)
                    8.2.1.1. Nucleic Acid test Kits
                           8.2.1.1.1. Transcription-mediated amplification (TMA)
                           8.2.1.1.2. Polymerase chain reaction (PCR)
                           8.2.1.1.3. Ligase chain reaction (LCR)
                           8.2.1.1.4. Whole genome sequencing
                    8.2.1.2. Consumables

          8.2.2. Europe Nucleic Acid Testing Market by Indication
                    8.2.2.1. Infectious diseases
                    8.2.2.2. Cancer
                    8.2.2.3. Forensic Testing
                    8.2.2.4. Others

          8.2.3. Europe Nucleic Acid Testing Market by End User
                    8.2.3.1. Hospitals
                    8.2.3.2. Pathology laboratories
                    8.2.3.3. Research Institutes
                    8.2.3.4. Clinics

     8.3. Asia-Pacific Nucleic Acid Testing Market Revenue Forecast till 2025
          8.3.1. Asia-Pacific Nucleic Acid Testing Market by Product Type (Option 3: 25% customization)
                    8.3.1.1. Nucleic Acid test Kits
                           8.3.1.1.1. Transcription-mediated amplification (TMA)
                           8.3.1.1.2. Polymerase chain reaction (PCR)
                           8.3.1.1.3. Ligase chain reaction (LCR)
                           8.3.1.1.4. Whole genome sequencing
                    8.3.1.2. Consumables

          8.3.2. Asia-Pacific Nucleic Acid Testing Market by Indication
                    8.3.2.1. Infectious diseases
                    8.3.2.2. Cancer
                    8.3.2.3. Forensic Testing
                    8.3.2.4. Others

          8.3.3. Asia-Pacific Nucleic Acid Testing Market by End User
                    8.3.3.1. Hospitals
                    8.3.3.2. Pathology laboratories
                    8.3.3.3. Research Institutes
                    8.3.3.4. Clinics

     8.4. Rest of the World Nucleic Acid Testing Market Revenue Forecast till 2025
          8.4.1. Rest of the World Nucleic Acid Testing Market by Product Type (Option 4: 25% customization)
                    8.4.1.1. Nucleic Acid test Kits
                           8.4.1.1.1. Transcription-mediated amplification (TMA)
                           8.4.1.1.2. Polymerase chain reaction (PCR)
                           8.4.1.1.3. Ligase chain reaction (LCR)                            8.4.1.1.4. Whole genome sequencing
                    8.4.1.2. Consumables

          8.4.2. Rest of the World Nucleic Acid Testing Market by Indication
                    8.4.2.1. Infectious diseases
                    8.4.2.2. Cancer
                    8.4.2.3. Forensic Testing
                    8.4.2.4. Others

          8.4.3. Rest of the World Nucleic Acid Testing Market by End User
                    8.4.3.1. Hospitals
                    8.4.3.2. Pathology laboratories
                    8.4.3.3. Research Institutes
                    8.4.3.4. Clinics

9. Competitive Landscape
     9.1. Industry Attractiveness
     9.2. Porter 5 Analysis
     9.3. Major players and their key strategies
     9.4. Company Share Analysis

10. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
       10.1. Agilent Technologies
             10.1.1.1. Company Overview
             10.1.1.2. Financials
             10.1.1.3. Recent Developments

       10.2. Danaher Corporation
             10.2.1.1. Company Overview
             10.2.1.2. Financials
             10.2.1.3. Recent Developments

       10.3. Abbott Laboratories, Inc.
             10.3.1.1. Company Overview
             10.3.1.2. Financials
             10.3.1.3. Recent Developments

       10.4. Becton, Dickinson and Company
             10.4.1.1. Company Overview
             10.4.1.2. Financials
             10.4.1.3. Recent Developments

       10.5. Bio-Rad Laboratories Inc.
             10.5.1.1. Company Overview
             10.5.1.2. Financials
             10.5.1.3. Recent Developments

       10.6. F. Hoffmann-La Roche Ltd.
             10.6.1.1. Company Overview
             10.6.1.2. Financials
             10.6.1.3. Recent Developments

       10.7. Illumina, Inc.
             10.7.1.1. Company Overview
             10.7.1.2. Financials
             10.7.1.3. Recent Developments

       10.8. Thermo Fisher Scientific Inc.
             10.8.1.1. Company Overview
             10.8.1.2. Financials
             10.8.1.3. Recent Developments

       10.9. Qiagen
             10.9.1.1. Company Overview
             10.9.1.2. Financials
             10.9.1.3. Recent Developments

       10.10. Merck KGaA,
             10.10.1.1. Company Overview
             10.10.1.2. Financials
             10.10.1.3. Recent Developments

11. About GMI Research